Search - tctmd.com

Displaying 141 - 157 of 157

Sort: Relevancy | Date

News Conference News

DES Noninferior for Survival Compared with BMS in STEMI

November 06, 2011

News Conference News

ACTIVE Results Demonstrate Safety and Efficacy of Cobalt Chromium Stent in Treatment of PVD

November 06, 2011

News Industry News

Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent

November 01, 2011

News Industry News

Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac Arteries

October 31, 2011

News Industry News

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

October 05, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Industry News

Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease

August 10, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Industry News

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

June 26, 2011

News Daily News

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

L.A. McKeown

June 15, 2011

News Industry News

Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels

May 24, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

L.A. McKeown

April 05, 2011

News Daily News

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

L.A. McKeown

March 10, 2011

News Daily News

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Jason Kahn

February 23, 2011

News Industry News

Edwards Lifesciences Expands Treatable Patient Population With European Approval of Larger Transcatheter Valve

February 23, 2011

Advertisement

DES Noninferior for Survival Compared with BMS in STEMI

ACTIVE Results Demonstrate Safety and Efficacy of Cobalt Chromium Stent in Treatment of PVD

Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent

Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac Arteries

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Edwards Lifesciences Expands Treatable Patient Population With European Approval of Larger Transcatheter Valve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content